SYK STRYKER CORPORATION

Stryker named to the 100 Best Companies to Work For list for 10th consecutive year

Stryker named to the 100 Best Companies to Work For list for 10th consecutive year

Kalamazoo, Michigan, Feb. 18, 2020 (GLOBE NEWSWIRE) -- Kalamazoo, Michigan – February 18, 2020 – Stryker (NYSE:SYK), one of the world’s leading medical technology companies, announced today it has been named one of in its annual survey and evaluation of top-rated workplaces in the United States for a 10th consecutive year. The list recognizes companies that have exceptional workplace cultures and Stryker was ranked #8.  

“Being named to the 100 Best Companies to Work For list for a decade is an honor that we attribute to our people and culture,” said Katy Fink, Vice President, Chief Human Resources Officer, Stryker. “Our employees are driven to deliver on our mission to make healthcare better. We celebrate them and their many contributions that make Stryker a great place to work.”

Fortune partners with research firm Great Place to Work (GPTW) to create the list. GPTW scores each company on its analysis of anonymous employee responses to more than 60 questions on the Trust Index Survey. More than 650,000 employees from various companies in the United States participated in the survey. In addition, GPTW evaluated each companies’ programs and practices as measured through its Culture Audit© assessment.

GPTW ranks the 100 Best Companies to Work For by comparing participants’ scores against similarly sized peers to choose companies that perform the best on characteristics such as being a great place to work for all, executive team effectiveness, innovation and people-focused programs. GPTW research shows that list winners outperform the stock market, beating industry rivals when it comes to talent retention and demonstrating higher levels of productivity than their peers.

About Stryker

Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. More information is available at .

Contacts

For investor inquiries please contact:

Katherine Owen, Vice President, Strategy & Investor Relations at 269-385-2600 or

For media inquiries please contact:

Yin Becker, Vice President, Communications, Public Affairs and Corporate Marketing at 269-385-2600 or

EN
18/02/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on STRYKER CORPORATION

Stryker Corp: 1 director

A director at Stryker Corp sold 1,241 shares at 388.560USD and the significance rating of the trade was 64/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...

 PRESS RELEASE

Stryker declares an $0.84 per share quarterly dividend

Stryker declares an $0.84 per share quarterly dividend Portage, Michigan, May 08, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.84 per share payable July 31, 2025, to shareholders of record at the close of business on June 30, 2025, representing an increase of 5.0% versus the prior year and unchanged from the previous quarter.  About Stryker Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in ...

 PRESS RELEASE

Stryker reports first quarter 2025 operating results

Stryker reports first quarter 2025 operating results Portage, Michigan, May 01, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the first quarter of 2025: First Quarter Results Reported net sales increased 11.9% to $5.9 billionOrganic net sales increased 10.1%Reported operating income margin of 14.3%Adjusted operating income margin(1) increased 100 bps to 22.9%Reported EPS decreased 17.6% to $1.69Adjusted EPS(1) increased 13.6% to $2.84  First Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures Org...

 PRESS RELEASE

Stryker to participate in the Bank of America Securities 2025 Global H...

Stryker to participate in the Bank of America Securities 2025 Global Healthcare Conference Portage, Michigan, April 29, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the Bank of America Securities 2025 Global Healthcare Conference on Tuesday, May 13, 2025, at the Encore at Wynn Hotel in Las Vegas, Nevada. Representing the company will be Preston Wells, Vice President and Chief Financial Officer, and Jason Beach, Vice President, Finance and Investor Relations. Their presentation is scheduled for 1:40 p.m. Pacific Time. A live webcast and replay of the presentation will ...

 PRESS RELEASE

Stryker to announce financial results for its first quarter of fiscal ...

Stryker to announce financial results for its first quarter of fiscal year 2025 Portage, Michigan, April 07, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for its first quarter of fiscal year 2025 on Thursday, May 1, 2025.  A press release will be issued at approximately 4:05 p.m. ET and available at that day. The press release will include summary financial information for the company’s first quarter that ended March 31, 2025. Stryker will host a webcast at 4:30 p.m. ET on Thursday, May 1, 2025, to discuss its first quarter 2025 results.  ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch